Hennigsdorf (Berlin), Germany
At 4TEEN4, we are tackling a high and unmet medical need in the intensive care units worldwide, namely the loss of heart function leading to circulatory shock. Circulatory shock is one of the global leading causes of death and the most frequent reason for intensive care unit admission.
Essen, Germany
Our fully automated machines enable the fastest, easiest and most reliable supply of colloidal nanoparticles, anywhere, anytime and for anyone.
Lennestadt, Germany
X-ZELL is fusing next-generation single-cell detection technology with artificial intelligence to identify clinically significant cancers at the earliest stages – non-invasively, accurately and affordably.
Berlin, Germany
We have a patented technology for the synthesis of bio-aromatics from agricultural waste.
Our goal is to replace phenolic bases for adhesives, coatings, surfactants, foams and more, for applications.
Düsseldorf, Germany
The key goal of CureDiab is the development of novel GABA-A receptor modulators as a first-in-class therapy of fatty liver disease.